Hasil Pencarian - Yu-Feng Wei
- Menampilkan 1 - 20 hasil dari 40
- Ke Halaman Berikutnya
-
1
Candidates for Bariatric Surgery: Morbidly Obese Patients with Pulmonary Dysfunction oleh Yu-Feng Wei, Huey-Dong Wu
Diterbitkan 2012-01-01
Artikel -
2
Comparison of clinically indicated replacement and routine replacement of peripheral intravenous catheters: A systematic review and meta-analysis of randomized controlled trials oleh Ching-Yi Chen, Wang-Chun Chen, Wang-Chun Chen, Jung-Yueh Chen, Jung-Yueh Chen, Chih-Cheng Lai, Yu-Feng Wei, Yu-Feng Wei, Yu-Feng Wei
Diterbitkan 2022-08-01
Artikel -
3
Influence of Rifamycin on Survival in Patients with Concomitant Lung Cancer and Pulmonary Tuberculosis oleh Ho-Sheng Lee, Yu-Feng Wei, Chin-Chung Shu
Diterbitkan 2023-11-01
Artikel -
4
Hemothorax Due to Metastatic Hepatocellular Carcinoma Presenting with Massive Hemoptysis oleh Yu-Feng Wei, Hao-Chien Wang, Yi-Chen Chang
Diterbitkan 2006-01-01
Artikel -
5
Aquabis(2-methyl-4-oxopyrido[1,2-a]pyrimidin-9-olato)zinc(II) monohydrate oleh Yu-Feng Wei, Zhong-Shu Li, Huai-Hong Zhang, Yi-Hong Wang
Diterbitkan 2009-01-01
Artikel -
6
-
7
Successful Treatment of Intractable Hemothorax with Recombinant Factor VIIa in a Nonhemophilic Patient oleh Yu-Feng Wei, Chao-Chi Ho, Ming-Tzer Lin, Ang Yuan, Chong-Jen Yu
Diterbitkan 2006-01-01
Artikel -
8
-
9
-
10
-
11
-
12
Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities oleh Chia-Yu Chu, Kuan-Yu Chen, John Wen-Cheng Chang, Yu-Feng Wei, Chih-Hung Lee, Wei-Ming Wang
Diterbitkan 2017-06-01
Artikel -
13
Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase... oleh Cheng-Yu Chang, Cheng-Yu Chang, Chung-Yu Chen, Chung-Yu Chen, Shih-Chieh Chang, Shih-Chieh Chang, Shih-Chieh Chang, Ching-Yi Chen, Yi-Chun Lai, Yi-Chun Lai, Chun-Fu Chang, Chun-Fu Chang, Yu-Feng Wei, Yu-Feng Wei
Diterbitkan 2023-06-01
Artikel -
14
-
15
-
16
Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients oleh You-Yi Chen, Shih-Chieh Chang, Cheng-Yu Chang, Chun-Fu Chang, Yi-Chun Lai, Yu-Feng Wei, Chung-Yu Chen
Diterbitkan 2021-11-01
Artikel -
17
Circulating mRNA Expression of Astrocyte-Elevated Gene-1 Associated with Treatment Response and Survival in Non-Small Cell Lung Cancer Patients Treated with Pemetrexed oleh You-Lung Chang, Yen-Fu Chen, Ying-Yin Chen, Shih-Chieh Chang, Cheng-Yu Chang, Yu-Feng Wei, Chung-Yu Chen
Diterbitkan 2021-11-01
Artikel -
18
Corrigendum: Clinical radiomics-based machine learning versus three-dimension convolutional neural network analysis for differentiation of thymic epithelial tumors from other preva... oleh Chao-Chun Chang, En-Kuei Tang, Yu-Feng Wei, Yu-Feng Wei, Chia-Ying Lin, Fu-Zong Wu, Fu-Zong Wu, Fu-Zong Wu, Ming-Ting Wu, Ming-Ting Wu, Ming-Ting Wu, Yi-Sheng Liu, Yi-Ting Yen, Yi-Ting Yen, Mi-Chia Ma, Yau-Lin Tseng
Diterbitkan 2023-05-01
Artikel -
19
Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan oleh Cheng-Yu Chang, Cheng-Yu Chang, Yu-Feng Wei, Yu-Feng Wei, Chung-Yu Chen, Chung-Yu Chen, Yi-Chun Lai, Yi-Chun Lai, Po-Wei Hu, Po-Wei Hu, Jui-Chi Hung, Chi-Hsiang Chu, Hsin-Tzu Chuang, Shih-Chieh Chang, Shih-Chieh Chang, Shih-Chieh Chang
Diterbitkan 2023-10-01
Artikel -
20
Clinical radiomics-based machine learning versus three-dimension convolutional neural network analysis for differentiation of thymic epithelial tumors from other prevascular medias... oleh Chao-Chun Chang, En-Kuei Tang, Yu-Feng Wei, Yu-Feng Wei, Chia-Ying Lin, Fu-Zong Wu, Fu-Zong Wu, Fu-Zong Wu, Ming-Ting Wu, Ming-Ting Wu, Ming-Ting Wu, Yi-Sheng Liu, Yi-Ting Yen, Yi-Ting Yen, Mi-Chia Ma, Yau-Lin Tseng
Diterbitkan 2023-04-01
Artikel